It's All About-Research Funding-Riverside-Type None Diabetes
Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the leading global organization funding type 1 diabetes (T1D) research. Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. JDRF works every day to change this by amassing grassroots support, deep scientific knowledge and strong industry and academic partnerships to fund research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until they achieve a world without T1D.
JDRF is a major charitable 501 organization dedicated to funding type 1 diabetes research. JDRF’s stated vision is “a world without type 1 diabetes.” Riverside was founded in the early 1870s and is the birthplace of the California citrus industry as well as home of the Mission Inn, the largest Mission Revival Style building in the United States. It is also home to the Riverside National Cemetery. The University of California, Riverside, is located in the northeastern part of the city. The university also hosts the Riverside Sports Complex. Other attractions in Riverside include the Fox Performing Arts Center, Riverside Metropolitan Museum, which houses exhibits and artifacts of local history, the California Museum of Photography, the California Citrus State Historic Park, and the Parent Washington Navel Orange Tree, the last of the two original navel orange trees in California. Full list of Video Credit see here http://broadcaster.beazil.net/public/credits/youtube/videos/42094 Type 1 diabetes (T1D) kills the body’s beta cells that produce insulin which gives us the energy we need for everyday life. JDRF’s vision, the Beta Cell Restoration Program, will not only stop the autoimmune attack but also return the number of beta cells to a normal level. JDRF is developing vaccines that will re-train the immune system to eliminate autoimmunity and leave the beta cells alone. Type 1 diabetes (T1D) can occur in anyone—not just kids. If you or an adult you know has recently been diagnosed with T1D, check out the JDRF T1D Care Kit, a free resource containing information and tools to educate, support and inspire newly diagnosed adults. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important to point out the main points –
insulin dependent,donation,eAG,treatment,diabetic,hyperglycemia,Cure,early detection of diabetes,diabetes management,undiagnosed diabetes,ADVANCE Trial,repaglinide,NovoLog,Glucose,patient-driven care,glycemic control,ultralente insulin,Translating Research Into Action for Diabetes Study,DonorDrive,make a tax-deductive donation,Bolus insulin,Robert Wood Johnson IV,no insulin production,SGLT2 inhibitors,ketone,maturity-onset diabetes of the young,join,CGM,NIDDM,Research Funding,Non-Profit Foundation,very-low-density lipoprotein cholesterol,symptoms of T1D,insulin therapy,Hypoglycemia Prevention,ASPIRE Trial,TRIAD Results,diabetes self-management education,JDRF family,EsTiD,Autoantigen Specific Immune Therapies,basal rate,Cure research,diabetes diagnosis,Long Acting Insulin,NDEP,contribution,Riverside,Insulin Pump Therapy,insulin glargine,oral hypoglycemic agents,Clinical Trials,Medical Research Council,Pathaway to Prevention,Diabetes Control and Complications Trial,NPH insulin,Type 1 Diabetes,The Kumamoto Study,Food insecurity (FI),Sodium–glucose cotransporter 2 inhibitors,blood glucose target range,diabetes care concepts,become an advocate,Insulin injections,A1C Test,Advocacy,Blood Glucose,T1D,Education,insulin receptors,SMBG,borderline diabetes,estimated average glucose,HAPO Study,blocking glucose.